Australia's most trusted
source of pharma news
Posted 29 October 2021 AM
The breakneck speed at which the TGA has assessed and approved COVID-19 vaccines and treatments has left the team exhausted with boss Professor John Skerritt revealing he has "welfare concerns" for his hard-working staff.
At Senate Estimate hearings this week, Skerritt detailed the unrelenting work associated with the pandemic, requiring staff at times to be on-duty seven days a week and work through holiday periods to get the job done.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.